Kanger is still in progressing state in its current business, which are a bamboo flooring and related products, and Kanger also in its plan to venture in other business activities.

1. The company already involved in the construction services.

2. In a process to acquire property for investment.

3. In a process to acquire a company which involved in a construction material trading.

4. And of course a plan for Covid-19 vaccine business. The company is on the last step to procure 5 - 10 million doses of the Sinopharm vaccine for the sale in Malaysia.

Without any good news. Maybe OKU_2020 and 8dragon can spam more lies. He He

@BilisMasin. Nano Tesla Rally. Maybe. He He He

16 July 2021, Kuala Lumpur, Malaysia

Malaysia government system TracAPM Covid-19 entry-registration, or SafeTravelPass Malaysia, is official government entry-registry and quarantine hotels booking portal.

SafeTravelPass (STP QR Code) is officially recognised by the government upon arrival in Malaysia. Travellers can now conveniently access to SafeTravelPass Malaysia for Covid-19 Entry-registration, directly book and pay for Covid-19 quarantine hotels and services online at official rates, and skip multiple forms entries, duplicate processes, and miss match of hotel room frustrations upon arrival in KLIA.


Source: https://nexgram.co/2021/07/16/malaysia-quarantine-hotels-to-apply-with-tracapm-qs-partner-program-from-1st-august-2021-16-jul-2021-news-coverage/

16 July 2021, Kuala Lumpur, Malaysia

Malaysia government system TracAPM Covid-19 entry-registration, or SafeTravelPass Malaysia, is official government entry-registry and quarantine hotels booking portal.

SafeTravelPass (STP QR Code) is officially recognised by the government upon arrival in Malaysia. Travellers can now conveniently access to SafeTravelPass Malaysia for Covid-19 Entry-registration, directly book and pay for Covid-19 quarantine hotels and services online at official rates, and skip multiple forms entries, duplicate processes, and miss match of hotel room frustrations upon arrival in KLIA.


Source: https://nexgram.co/2021/07/16/malaysia-quarantine-hotels-to-apply-with-tracapm-qs-partner-program-from-1st-august-2021-16-jul-2021-news-coverage/

Announcement of Bornoil PP by McQuire Bank
---------------------------------------------------------
02-Feb-2021 1,500,000 units @RM0.034
03-Feb-2021 1,500,000 units @RM0.034
09-Feb-2021 1,500,000 units @RM0.034
11-Feb-2021 2,000,000 units @RM0.033
16-Feb-2021 3,500,000 units @RM0.033
19-Feb-2021 3,500,000 units @RM0.033
22-Feb-2021 50,000,000 units @RM0.034
24-Feb-2021 4,000,000 units @RM0.034
01-Mar-2021 2,000,000 units @RM0.035
03-Mar-2021 2,500,000 units @RM0.035
04-Mar-2021 3,000,000 units @RM0.034
05-Mar-2021 4,000,000 units @RM0.032
08-Mar-2021 8,000,000 units @RM0.032
10-Mar-2021 7,000,000 units @RM0.033
12-Mar-2021 18,000,000 units @RM0.033
16-Mar-2021 6,000,000 units @RM0.033
18-Mar-2021 90,000,000 units @RM0.033
19-Mar-2021 20,000,000 units @RM0.037
29-Mar-2021 2,000,000 units @RM0.036
30-Mar-2021 7,000,000 units @RM0.036
31-Mar-2021 4,000,000 units @RM0.036
05-Apr-2021 8,000,000 units @RM0.037
07-Apr-2021 8,000,000 units @RM0.037
08-Apr-2021 10,000,000 units @RM0.037
13-Apr-2021 30,000,000 units @RM0.040
20-Apr-2021 5,000,000 units @RM0.040
26-Apr-2021 5,000,000 units @RM0.038
27-Apr-2021 5,000,000 units @RM0.037
30-Apr-2021 5,000,000 units @RM0.037
04-May-2021 12,500,000 units @RM0.037
12-May-2021 4,000,000 units @RM0.035
17-May-2021 5,000,000 units @RM0.034
18-May-2021 5,000,000 units @RM0.035
21-May-2021 5,000,000 units @RM0.035
27-May-2021 6,000,000 units @RM0.033
02-June-2021 4,000,000 units @RM0.034
03-June-2021 67,000,000 units @RM0.034
08-June-2021 5,000,000 units @RM0.034
10-June-2021 5,000,000 units @RM0.034
14-June-2021 7,500,000 units @RM0.033
16-June-2021 10,000,000 units @RM0.032
22-June-2021 7,000,000 units @RM0.032
05-July-2021 7,000,000 units @RM0.030
06-July-2021 7,000,000 units @RM0.030
09-July-2021 270,000,000 units @RM0.029
12-July-2021 115,000,000 units @RM0.029
14-July-2021 5,000,000 units @RM0.029
15-July-2021 8,000,000 units @RM0.030
16-July-2021 10,000,000 units @RM0.030

TOTAL UNITS SUBSCRIBED (Up to 21 July 2021) = 882,000,000 UNITS

Outstanding balance of PP shares unsubscribed is 323,827,550 units
(Based on the maximum PP = 1,205,827,550 units.

This suggested that Sinopharm's vaccine may be able to induce antibody-based responses against the two variants similar to the levels seen following natural infection, the paper said.

@18Kharmoni. Beli 6 sen jual 7 sen, beli 6.5 sen jual 7.5 sen. Beli 6.5 sen jual 7.5 sen. Tidak 3 kali ke tu.

@18KHarmoni. Awak betul lah. Hanya orang bodoh saja yang dah kutip untung dua atau tiga kali dalam masa dua minggu di kaunter ini. He He

Yes they already sold it started from the beginning they subscribe it.

If not, how come they never been the substantial share holder????

@18Kharmoni. By the way saya sendiri sudah 3 kali pancut. Separuh main kontra. Separuh simpan untuk medium term bagi tujuan RI. He He

Lightspeed Takde siapa nak beli saham ni dgn harga murah, kita nak jual je, pasal kaunter ni menipu duit shareholder
----------------

Ini baru betul. Orang yang amat cerdik sedang tunggu jual saham sambil mengutuk saham tersebut supaya jatuh.

Nampak buktinya yang songsang dengan apa sepatutnya.

Realitinya, normal bagi seseorang yang dalam proses nak jual sesuatu saham untuk beri berita yang baik tentang saham itu supaya ia naik dan mengurangkan kerugian.

Yang penting awak dapat beli harga murah.

Lightspeed, OKU_2020 dan 8dragon. Awak telah jual saham awak sebelum ini. Tiada lagi kepentingan.

Sebab itu sekarang badmouth hari-hari kaunter ini supaya awak akan dapat beli pada harga rendah. He He

@OKU_2020 a k.a MDP.

Yang betul hanya awak. Hari-hari cerita hantu yang tak betul. Biar orang cut loss rugi banyak-banyak. Orang lain mampos tak apa. Yang penting awak dapat beli harga murah.

Kalau bukan itu sebabnya, mungkin awak tak akan badmouth hari-hari kaunter ini. Terutama kaunter yang awak badmouth akan gol mengikut kata awak.

Rosak susu kerana nila setitik, Rosak company bukan kerana naysayer dan hater. He He

@OKU_2020 a.k.a. MDP.

Prinsip saya mudah saja. Tak akan cut loss kerana harapan masih ada terhadap Nexgram. Tak rugi selagi tak jual.....

Itulah sebab saya cari maklumat. Hendak dapatkan kepastian utamanya untuk buat keputusan sendiri. Berita itu juga saya sebarkan untuk share kepada rakan-rakan demi melawan naysayer dan hater seperti awak dan seangkatan dengannya.

@OKU_2020. kalau awk memang ada kemampuan mental yang normal, cuba teliti dengan sebenarnya keadaan kewangan Nexgram sekarang.

Adakah ia sebuah syarikat yang lebih teruk keadaannya dari segi FA?

Minta tolong ikhlas pada diri sendiri sekurang-kurangnya.

Tak takut eh.
Saya sekadar yang mampu tak akan biarkan ada MDP atau geng oppurtunist saham yang cuba takut-takutkan orang tanpa fakta betul dan fakta menyokong.

@Singapore88. Eid mubarak

@8dragon. ..... NG has nvr come up with positive notes to attract investors instead Ozura keep on selling as their cost is only 1.5 cents....

--------------------------------------

3. NEXGRAM
Issue price per share ($) Malaysian Ringgit (MYR) 0.0200

@8dragon. No. its from the 3QR 2021 report. Only "my personal comment" come from my analysis.

Please refer to the 3QR 2021 report at:

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3171550

@8dragon. The fake GN3 ghost was spoken lies.
She is using her "fake balls' to do her prediction.

The incoming 4QR 2021 will be better. The capital reduction will be rationalized in the company's accounts. The accumulated losses will change to small retained profit. The cash collected from the ICPS conversion. The revenues expected to increase. The company's shareholder equity on consolidated basis of its shares excluding treasury shares is at 56.47 %. No more GN3 listed issuer risk.

Please refer to:

https://klse.i3investor.com/blogs/mzm511/2021-07-01-story-h1567122502-SOME_ANALYSIS_FROM_THE_3QR_2021_OF_NEXGRAM_0096.jsp

Thank you. Selamat Hari Raya Aidil Adha juga untuk semua yang merayakannya. Maaf Zahir Batin

@Amzar007. Cakap pihak lain asyik nak scam. Kita sendiri scammer buta huruf yang diajar oleh "para guru scammer". He He.

Astrazeneza ada 3 holder bagi setiap jenis vaksin astrazeneza yang diluluskan NPRA.

Bil Registration No. Product name Holder

1 MAL21036009ACZ COVID-19 Vaccine AstraZeneca Solution for Injection ASTRAZENECA SDN. BHD.

2 MAL21076098AZ COVILO Suspension for Injection COVID-19 Vaccine (Vero Cell), Inactivated DUOPHARMA (M) SDN. BHD.

3 MAL21046125ACSZ CoronaVac Suspension for Injection COVID-19 Vaccine (Vero Cell), Inactivated PHARMANIAGA LIFESCIENCE SDN. BHD.

4 MAL21046001AZ COVID-19 Vaccine AstraZeneca Solution for Injection (The product approved by EMA is supplied under the Commercial name: Vaxzevria) KEMENTERIAN KESIHATAN MALAYSIA

5 MAL21066001ACSZ COVID-19 Vaccine AstraZeneca Solution for Injection ASTRAZENECA SDN. BHD.

6 MAL21076097ACZ Janssen COVID-19 Vaccine Suspension for Injection JOHNSON & JOHNSON SDN BHD

7 MAL21066049AZ COVID-19 Vaccine Janssen Suspension for Injection KEMENTERIAN KESIHATAN MALAYSIA

@Amzar007.

Setakat maklumat yang saya ada, tiada pun rekod dalam WHO yang menyatakan astrazeneza dari thailand diluluskan WHO. Bagaimana pula NPRA boleh luluskan astrazeneca dari thailand? Kalau awak ada maklumat boleh kemukakan, boleh kita sama-sama lihat.

Vaksin dari Arab dibuat under collaboration. Bermaksud, CNBG boleh authorize yang pengeluaran vaksin tersebut walaupun dibuat di Arab tetapi under authorization dari pemegang patent yang diluluskan oleh WHO. Sekadar pandangan saya saja.

@hlh1962. Agree.
and other idea is, sometimes the developer of the vaccine itself can't coop with excess demand for the vaccine and colloborate with other manufacturer from other countries to manufacture it.

The same happens to Astrazeneca. We are importing Astrazeneca vaccine from the manufacturer in Thailand.

UAE to begin manufacturing ‘Hayat-Vax’ Covid-19 vaccine
The ‘Life Sciences and Vaccine Manufacturing in the UAE’ is a joint project by the Abu Dhabi-based Group 42 and China’s Sinopharm CNBG

Source: https://gulfbusiness.com/uae-to-begin-manufacturing-covid-19-sinopharm-vaccine/

@hlh1962. Please read this.

Earlier this year, Sinopharm entered into a joint venture with UAE-based G42 to produce the Sinopharm Covid-19 vaccines in the country under the Hayat-Vax brand.

The made-in-UAE vaccine was the first Covid-19 vaccine to be produced in the Arab world.

"The Hayat-Vax vaccine is essentially the same Sinopharm Covid-19 vaccine, manufactured in the UAE. Hence, we are confident that it will be well-received and accepted by the Malaysian people as an effective vaccine towards the global fight against the Covid-19 pandemic," said Kuah.

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

On behalf of G42 Medications, Kanger said it had submitted applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency for the Hayat-Vax vaccine to be used in Malaysia.

@hlh1962. I just can do my guessing based on this report.
...................

Under the agreement, Sinopharm Group has appointed KIB as the sole distributor for the vaccines, medical devices and products in Malaysia. KIB will also undertake the marketing and promotion of Sinopharm Group's products in Malaysia, however, both parties WILL SIGN A SEPARATE AGREEMENT in regards to specific product category, price, purchase price and payment method.

Fahaman yang lagi sesat ialah kutuk kutuk kutuk saham yang kita pegang. Cut loss supaya rugi banyak.

Ini bukan fahaman yang sesat, tetapi fahaman orang kurang siuman. He He

Earlier this year, Sinopharm entered into a joint venture with UAE-based G42 to produce the Sinopharm Covid-19 vaccines in the country under the Hayat-Vax brand.

The made-in-UAE vaccine was the first Covid-19 vaccine to be produced in the Arab world.

"The Hayat-Vax vaccine is essentially the same Sinopharm Covid-19 vaccine, manufactured in the UAE. Hence, we are confident that it will be well-received and accepted by the Malaysian people as an effective vaccine towards the global fight against the Covid-19 pandemic," said Kuah.

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

On behalf of G42 Medications, Kanger said it had submitted applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency for the Hayat-Vax vaccine to be used in Malaysia.

The Board of Directors of Kanger (“Company”) wishes to announce that Kanger Medical International Sdn. Bhd., a wholly-owned subsidiary of the Company had, on 19 July 2021 entered into Head of Agreement with Sparmak Medical Equipment Trading LLC for purchase of inactivated SARS-COV-2 Vaccines (Vero Cell) vaccine developed by Beijing Institute of Biological Products Co. Ltd., an affiliate of SINOPHARM CNBG.

Please refer to the full announcement as attached.

This announcement is dated 19 July 2021.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3176295

4.1 Quantity and specification of the Products
Quantity: Five Million (5,000,000) doses with an option to buy an additional Five Million (5,000,000) doses.
Specification: SARS COV-2 vaccine (Vero cell) inactivated, 6.5 U/0.5ml in prefilled syringe or vial (as per availability) and pack size either 2 doses per vial per box or Single dose per vial per box (as per availability). The Product is manufactured by Gulf Pharmaceutical Industries Julphar in the United Arab Emirates (HAYAT-VAX), i.e. G42 Medications Trading LLC (“Manufacturer”).

Earlier this year, Sinopharm entered into a joint venture with UAE-based G42 to produce the Sinopharm Covid-19 vaccines in the country under the Hayat-Vax brand.

The made-in-UAE vaccine was the first Covid-19 vaccine to be produced in the Arab world.

"The Hayat-Vax vaccine is essentially the same Sinopharm Covid-19 vaccine, manufactured in the UAE. Hence, we are confident that it will be well-received and accepted by the Malaysian people as an effective vaccine towards the global fight against the Covid-19 pandemic," said Kuah.

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

On behalf of G42 Medications, Kanger said it had submitted applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency for the Hayat-Vax vaccine to be used in Malaysia.

Earlier this year, Sinopharm entered into a joint venture with UAE-based G42 to produce the Sinopharm Covid-19 vaccines in the country under the Hayat-Vax brand.

The made-in-UAE vaccine was the first Covid-19 vaccine to be produced in the Arab world.

"The Hayat-Vax vaccine is essentially the same Sinopharm Covid-19 vaccine, manufactured in the UAE. Hence, we are confident that it will be well-received and accepted by the Malaysian people as an effective vaccine towards the global fight against the Covid-19 pandemic," said Kuah.

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

On behalf of G42 Medications, Kanger said it had submitted applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency for the Hayat-Vax vaccine to be used in Malaysia.

Relax. Tak rugi selagi tak cut loss.

@18Kharmoni. Yang beli kanger kat pasaran tu bukan semuanya newbie. Bapak kepada investor/trader pun ada saya rasa.Itulah volume besar.

Arsenewenger8383 .... kanger will submit sinophram from UAE to get approval from NPRA?? Hehehe... how long need to wait again?
----------------------
On behalf of G42 Medications, Kanger has submitted the necessary applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency (NPRA) for the Hayat-Vax vaccine to be used in the country.

ADA KITA CONFIRM BILA DIA SUBMIT. Mungkin semasa MOU dengan Sabah dahulu pun kita TAK TAHU...

Kalau Kanger jadi main distributor kepada duopharma????? Bagaimana pula. Ada kemungkinankah?????. Memandangkan Kanger sebelum ini lebih awal menandatangani sebagai distributor bagi pihak sinopharm.

@Noobie123.

Under the agreement, Sinopharm Group has appointed KIB as the sole distributor for the vaccines, medical devices and products in Malaysia. KIB will also undertake the marketing and promotion of Sinopharm Group's products in Malaysia, however, both parties WILL SIGN A SEPARETE AGREEMENT in regards to specific product category, price, purchase price and payment method.

(Remarks: This agreement shall take effect for a period of three years effective from 25 September 2020 until 24 September 2023)

Source: https://www.msn.com/en-my/news/national/kanger-sinopharm-inks-agreement-for-covid-19-vaccine-distribution-in-malaysia/ar-BB19x0Lr

AND SEE: This one is the:

OTHERS KANGER INTERNATIONAL BERHAD ("KANGER" OR "THE GROUP") EXECUTION HEAD OF AGREEMENT

The Board of Directors of Kanger (“Company”) wishes to announce that Kanger Medical International Sdn. Bhd., a wholly-owned subsidiary of the Company had, on 19 July 2021 entered into Head of Agreement with Sparmak Medical Equipment Trading LLC for purchase of inactivated SARS-COV-2 Vaccines (Vero Cell) vaccine developed by Beijing Institute of Biological Products Co. Ltd., an affiliate of SINOPHARM CNBG.

Please refer to the full announcement as attached.

This announcement is dated 19 July 2021.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3176295

4.1 Quantity and specification of the Products

Quantity: Five Million (5,000,000) doses with an option to buy an additional Five Million (5,000,000) doses.

The Board of Directors of Kanger (“Company”) wishes to announce that Kanger Medical International Sdn. Bhd., a wholly-owned subsidiary of the Company had, on 19 July 2021 entered into Head of Agreement with Sparmak Medical Equipment Trading LLC for purchase of inactivated SARS-COV-2 Vaccines (Vero Cell) vaccine developed by Beijing Institute of Biological Products Co. Ltd., an affiliate of SINOPHARM CNBG.

Please refer to the full announcement as attached.

This announcement is dated 19 July 2021.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3176295

4.1 Quantity and specification of the Products
Quantity: Five Million (5,000,000) doses with an option to buy an additional Five Million (5,000,000) doses.
Specification: SARS COV-2 vaccine (Vero cell) inactivated, 6.5 U/0.5ml in prefilled syringe or vial (as per availability) and pack size either 2 doses per vial per box or Single dose per vial per box (as per availability). The Product is manufactured by Gulf Pharmaceutical Industries Julphar in the United Arab Emirates (HAYAT-VAX), i.e. G42 Medications Trading LLC (“Manufacturer”).

The Board of Directors of Kanger (“Company”) wishes to announce that Kanger Medical International Sdn. Bhd., a wholly-owned subsidiary of the Company had, on 19 July 2021 entered into Head of Agreement with Sparmak Medical Equipment Trading LLC for purchase of inactivated SARS-COV-2 Vaccines (Vero Cell) vaccine developed by Beijing Institute of Biological Products Co. Ltd., an affiliate of SINOPHARM CNBG.

Please refer to the full announcement as attached.

This announcement is dated 19 July 2021.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3176295

4.1 Quantity and specification of the Products
Quantity: Five Million (5,000,000) doses with an option to buy an additional Five Million (5,000,000) doses.
Specification: SARS COV-2 vaccine (Vero cell) inactivated, 6.5 U/0.5ml in prefilled syringe or vial (as per availability) and pack size either 2 doses per vial per box or Single dose per vial per box (as per availability). The Product is manufactured by Gulf Pharmaceutical Industries Julphar in the United Arab Emirates (HAYAT-VAX), i.e. G42 Medications Trading LLC (“Manufacturer”).

1. Sinopharm COVID vaccine: the world needs to keep using it, even if it’s less effective than Pfizer

Source: https://theconversation.com/sinopharm-covid-vaccine-the-world-needs-to-keep-using-it-even-if-its-less-effective-than-pfizer-162207

2. Health officials have stressed that all the COVID-19 vaccines are effective, saying “the best vaccine is the one that’s available”.

Source: https://www.aljazeera.com/news/2021/7/16/how-effective-are-chinas-sinovac-and-sinopharm-vaccines

@NicmannNg. It's true. Just to give an idea from a different angle. He He.

The final conclusion is, only the demand and supply of the shares in the market will determine the share price.

On the Sputnik Covid-19 vaccine produced by Russia, Khairy said that Duopharma Biotech Bhd’s wholly-owned subsidiary, Duopharma (M) Sdn Bhd (DMSB), which holds the distribution rights to the product, has three months to register the vaccine with the National Pharmaceutical Regulatory Agency (NPRA), after inking an agreement with the government earlier this month.

He said that the NPRA still requires further information on the vaccine.

“However, NPRA also said that it would simplify the registration process if Sputnik gets emergency use (status) from the World Health Organisation (WHO). Sputnik has not received the EUL from WHO yet,” he said, referring to the Emergency Use Listing.

Source: https://www.malaymail.com/news/malaysia/2021/06/21/khairy-cansino-vaccine-to-arrive-in-malaysia-next-month-no-updates-yet-on-j/1983852

Khairy also mentioned that Covid-19 vaccines will enter the private market by August. He said that private vaccination will help the government ramp up the national Covid-19 vaccination programme, as those who are able to pay for the vaccines will be able to do so.

“I also anticipate by about August, we will have a private vaccine market. So right now, it’s difficult for private because vaccines are in short supply. But by August, I think that there will be SOME COMPANIES who WILL BE APPROVED to bring in SOME PRIVATE VACCINES from China. I know Sinopharm and all that are going to be registered here,” Khairy added.

“That’s also part of the plan. I’ve been talking to the Ministry of Health to ensure that the private market by August can take off to help us.”

Source: https://codeblue.galencentre.org/2021/06/24/khairy-projects-40-population-fully-vaccinated-by-end-august/

Report 3: Covid-19: Those who want to bring in Sinopharm vaccine can register it with NPRA, says Khairy.

(Source: https://www.thestar.com.my/news/nation/2021/05/21/covid-19-those-who-want-to-bring-in-sinopharm-vaccine-can-register-it-with-npra-says-khairy )

Report 6: The states are free to negotiate with drug makers Moderna and Sinopharm, whose vaccines have been approved by the World Health Organization . Khairy said that as long as the vaccines have been given the green light by the National Pharmaceutical Regulatory Agency, the states are free to procure them.

(Source: https://www.freemalaysiatoday.com/category/nation/2021/06/03/state-govts-free-to-purchase-moderna-sinopharm-vaccines/ )

Report 2: Kanger International executive director Steven Kuah told reporters that, “the process of registering the Sinopharm vaccine (with NPRA) has started and we hope to receive some good news on its approval soon.”

(Source: https://www.freemalaysiatoday.com/category/nation/2021/05/27/sabah-signs-mou-with-private-firm-to-obtain-sinopharm-vaccine/ )

Report 6: The states are free to negotiate with drug makers Moderna and Sinopharm, whose vaccines have been approved by the World Health Organization . Khairy said that as long as the vaccines have been given the green light by the National Pharmaceutical Regulatory Agency, the states are free to procure them.

(Source: https://www.freemalaysiatoday.com/category/nation/2021/06/03/state-govts-free-to-purchase-moderna-sinopharm-vaccines/ )

Khairy also mentioned that Covid-19 vaccines will enter the private market by August. He said that private vaccination will help the government ramp up the national Covid-19 vaccination programme, as those who are able to pay for the vaccines will be able to do so.

“I also anticipate by about August, we will have a private vaccine market. So right now, it’s difficult for private because vaccines are in short supply. But by August, I think that there will be SOME COMPANIES who WILL BE APPROVED to bring in SOME PRIVATE VACCINES from China. I know Sinopharm and all that are going to be registered here,” Khairy added.

“That’s also part of the plan. I’ve been talking to the Ministry of Health to ensure that the private market by August can take off to help us.”

Source: https://codeblue.galencentre.org/2021/06/24/khairy-projects-40-population-fully-vaccinated-by-end-august/

@Noobie123. The facts is the second one not yet approved by WHO. If Kanger relating to that one, it could be a late comer. By the way, I can't give the answer about which vaccines referred to Kanger.